This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
medical-devices: Archive
Implied Volatility Surging for Phibro Animal Health (PAHC) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Phibro Animal Health (PAHC) stock based on the movements in the options market lately.
PAHCPositive Net Change
medical-devices
Pediatrix Medical Group (MD)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
MDPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Implied Volatility Surging for National Vision (EYE) Stock Options
by Zacks Equity Research
Investors need to pay close attention to National Vision (EYE) stock based on the movements in the options market lately.
EYENegative Net Change
medical medical-devices
McKesson Shares Fall Following Sale of Rexall, Well.ca to Birch Hill
by Zacks Equity Research
MCK announces the sale of its Canada-based Rexall and Well.ca businesses to Birch Hill Equity Partners, aligning with its strategy to grow oncology and biopharma services.
DGXNegative Net Change UHSPositive Net Change MCKNegative Net Change ABMPositive Net Change
medical medical-devices
With HOLX Stock Near 52-Week High, Should You Buy More or Play Safe?
by Moumi Mondal
Hologic's business diversification holds strong potential internationally. Also, its discounted valuation makes it attractive from an investment perspective.
BDXPositive Net Change HOLXPositive Net Change QGENNegative Net Change
medical medical-devices oncology-screening
Reasons to Retain Revvity Stock in Your Portfolio for Now
by Zacks Equity Research
RVTY's strong product portfolio raises optimism about the stock.
BSXPositive Net Change UHSPositive Net Change APYXPositive Net Change RVTYPositive Net Change
medical medical-devices
Bull of the Day: DaVita (DVA)
by Shaun Pruitt
Seeing as DaVita's (DVA) growth is also crucial to societal health, its valuation is very intriguing at the moment as the leading provider of kidney care services in the United States.
DVANegative Net Change
earnings investing medical medical-devices
HealthEquity Stock May Gain From Its Latest Partnership With Paytient
by Zacks Equity Research
HQY collaborates with Paytient to enhance employees' access to healthcare through Health Payment Accounts.
DGXNegative Net Change UHSPositive Net Change ABMPositive Net Change HQYPositive Net Change
medical medical-devices
Intuitive Surgical Gains 40.5% Year to Date: What's Driving the Stock?
by Zacks Equity Research
ISRG's shares gain on the back of strength in da Vinci surgical system.
DGXNegative Net Change UHSPositive Net Change ISRGPositive Net Change ABMPositive Net Change
medical medical-devices
Hims & Hers Stock Plunges 32.1% in Three Months: What's Next?
by Debanjana Dey
HIMS is enhancing its offerings and expanding the breadth of health and wellness products and services. However, macro challenges are likely to hurt its performance.
ABTNegative Net Change TDOCPositive Net Change HIMSPositive Net Change
medical medical-devices
BD Stock Falls After Acquisition of Edwards' Critical Care Group
by Zacks Equity Research
BDX expands its smart care portfolio by acquiring Edwards Lifesciences' Critical Care group, now BD Advanced Patient Monitoring, strengthening AI-driven health solutions.
BDXPositive Net Change DGXNegative Net Change UHSPositive Net Change EWNegative Net Change
medical medical-devices
After Golden Cross, Aspen Technology (AZPN)'s Technical Outlook is Bright
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
AZPNPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Continue to Retain ABT Stock in Your Portfolio Now?
by Zacks Equity Research
Abbott's robust strength in Core Diagnostics and EPD businesses should continue to benefit in the upcoming quarters.
ABTNegative Net Change BSXPositive Net Change VCYTPositive Net Change TMDXPositive Net Change
medical medical-devices
Butterfly Network's Stock Surges on iQ3 Device Launch in Europe
by Zacks Equity Research
Shares of BFLY gain almost 27% following the announcement of the launch of its latest handheld ultrasound device, Butterfly iQ3, in Europe.
BSXPositive Net Change UHSPositive Net Change APYXPositive Net Change BFLYPositive Net Change
medical medical-devices
HealthEquity Stock Rises on Q2 Earnings and Revenue Beat
by Zacks Equity Research
HQY surpasses second-quarter expectations on robust HSA growth and improved margins. It also raises FY25 guidance.
DGXNegative Net Change UHSPositive Net Change ABMPositive Net Change HQYPositive Net Change
medical medical-devices
AngioDynamics Stock Falls Despite CE Mark for Auryon System
by Zacks Equity Research
ANGO's Auryon Atherectomy System earns CE Mark, which expands its European market reach and enhances PAD treatment with advanced laser technology.
ANGOPositive Net Change DGXNegative Net Change UHSPositive Net Change ABMPositive Net Change
medical medical-devices
Buy These 3 Medical Info Systems Stocks to Capitalize on GenAI Boom
by Urmimala Biswas
Zacks Medical Info Systems industry stocks like Inspire Medical Systems, Clover Health Investments and CareCloud are expected to gain from the GenAI wave.
INSPPositive Net Change CLOVPositive Net Change CCLDPositive Net Change
medical medical-devices smart-health
Crown Holdings (CCK)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
CCKPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Reasons to Retain Cardinal Health Stock in Your Portfolio Now
by Zacks Equity Research
CAH gains from a solid pharmaceutical segment and a diversified product portfolio. However, regulatory setbacks are a concern.
BSXPositive Net Change UHSPositive Net Change CAHNegative Net Change APYXPositive Net Change
medical medical-devices
Embecta Stock Gains on FDA Clearance for Type 2 Diabetes Insulin Pump
by Zacks Equity Research
EMBC's shares close higher following FDA clearance for its disposable patch pump for insulin delivery, expanding the target market with its availability for type 2 diabetes.
BSXPositive Net Change UHSPositive Net Change APYXPositive Net Change EMBCPositive Net Change
medical medical-devices
Should You Consider Retaining ZBH Stock in Your Portfolio Now?
by Zacks Equity Research
Zimmer Biomet's robust efforts to expand the Knee business and a gradually stabilizing musculoskeletal market appear promising.
BSXPositive Net Change ZBHPositive Net Change VCYTPositive Net Change TMDXPositive Net Change
medical medical-devices
EW Stock Dips Following the Divestiture of Critical Care Wing
by Zacks Equity Research
Edwards completes the sale of its Critical Care operations and announces a $1 billion share repurchase program.
BDXPositive Net Change EWNegative Net Change AXGNPositive Net Change EXASPositive Net Change
medical medical-devices
Should You Continue to Retain PODD Stock in Your Portfolio Now?
by Zacks Equity Research
Insulet's Omnipod 5 is set to drive growth in the upcoming quarters. Meanwhile, the stock is facing challenges due to economic uncertainties.
BSXPositive Net Change PODDPositive Net Change VCYTPositive Net Change TMDXPositive Net Change
medical medical-devices
Top Medical Stocks to Hedge Against the September Effect
by Shaun Pruitt
Often sought out for defensive protection amid heightened market volatility, medical stocks may be of interest to investors in September which has historically been the most challenging month for stocks.
LLYPositive Net Change DVANegative Net Change HCAPositive Net Change
earnings hospitals investing large-cap medical medical-devices pharmaceuticals stock-performance value-stocks volatility
Greenville Center to Boost CAH Stock's at-Home Solution Business
by Zacks Equity Research
Cardinal Health announces the opening of its new distribution center in Greenville to support its at-Home Solutions business.
DGXNegative Net Change UHSPositive Net Change CAHNegative Net Change ABMPositive Net Change
medical medical-devices